nodes	percent_of_prediction	percent_of_DWPC	metapath
Gentamicin—Nephrotoxicity—Teniposide—lymphatic system cancer	0.0364	0.0364	CcSEcCtD
Gentamicin—Neurotoxicity—Teniposide—lymphatic system cancer	0.0299	0.0299	CcSEcCtD
Gentamicin—Neurotoxicity—Fludarabine—lymphatic system cancer	0.0262	0.0262	CcSEcCtD
Gentamicin—Pulmonary fibrosis—Fludarabine—lymphatic system cancer	0.0231	0.0231	CcSEcCtD
Gentamicin—Nephrotoxicity—Carmustine—lymphatic system cancer	0.0205	0.0205	CcSEcCtD
Gentamicin—Nephropathy toxic—Teniposide—lymphatic system cancer	0.0202	0.0202	CcSEcCtD
Gentamicin—Oliguria—Mechlorethamine—lymphatic system cancer	0.017	0.017	CcSEcCtD
Gentamicin—Pulmonary fibrosis—Bleomycin—lymphatic system cancer	0.017	0.017	CcSEcCtD
Gentamicin—Neurotoxicity—Vincristine—lymphatic system cancer	0.016	0.016	CcSEcCtD
Gentamicin—Pulmonary fibrosis—Carmustine—lymphatic system cancer	0.0148	0.0148	CcSEcCtD
Gentamicin—Extravasation—Teniposide—lymphatic system cancer	0.0133	0.0133	CcSEcCtD
Gentamicin—Nephropathy toxic—Bleomycin—lymphatic system cancer	0.013	0.013	CcSEcCtD
Gentamicin—Numbness—Fludarabine—lymphatic system cancer	0.0123	0.0123	CcSEcCtD
Gentamicin—Sensory loss—Fludarabine—lymphatic system cancer	0.0117	0.0117	CcSEcCtD
Gentamicin—Hypomagnesaemia—Bleomycin—lymphatic system cancer	0.0117	0.0117	CcSEcCtD
Gentamicin—Nephropathy toxic—Carmustine—lymphatic system cancer	0.0113	0.0113	CcSEcCtD
Gentamicin—Hypocalcaemia—Fludarabine—lymphatic system cancer	0.0111	0.0111	CcSEcCtD
Gentamicin—Hearing impaired—Fludarabine—lymphatic system cancer	0.0107	0.0107	CcSEcCtD
Gentamicin—Nephropathy toxic—Mitoxantrone—lymphatic system cancer	0.0105	0.0105	CcSEcCtD
Gentamicin—Encephalopathy—Carmustine—lymphatic system cancer	0.0101	0.0101	CcSEcCtD
Gentamicin—Phlebitis—Teniposide—lymphatic system cancer	0.00975	0.00975	CcSEcCtD
Gentamicin—Phlebitis—Fludarabine—lymphatic system cancer	0.00857	0.00857	CcSEcCtD
Gentamicin—Extravasation—Bleomycin—lymphatic system cancer	0.00855	0.00855	CcSEcCtD
Gentamicin—Deafness—Fludarabine—lymphatic system cancer	0.00825	0.00825	CcSEcCtD
Gentamicin—Agranulocytosis—Mechlorethamine—lymphatic system cancer	0.0082	0.0082	CcSEcCtD
Gentamicin—Injection site pain—Carmustine—lymphatic system cancer	0.00797	0.00797	CcSEcCtD
Gentamicin—Visual disturbance—Fludarabine—lymphatic system cancer	0.00779	0.00779	CcSEcCtD
Gentamicin—Neurotoxicity—Methotrexate—lymphatic system cancer	0.00778	0.00778	CcSEcCtD
Gentamicin—Numbness—Vincristine—lymphatic system cancer	0.0075	0.0075	CcSEcCtD
Gentamicin—Extravasation—Carmustine—lymphatic system cancer	0.00746	0.00746	CcSEcCtD
Gentamicin—Tinnitus—Mechlorethamine—lymphatic system cancer	0.00735	0.00735	CcSEcCtD
Gentamicin—Sensory loss—Vincristine—lymphatic system cancer	0.00717	0.00717	CcSEcCtD
Gentamicin—Extravasation—Vincristine—lymphatic system cancer	0.00712	0.00712	CcSEcCtD
Gentamicin—Alopecia—Mechlorethamine—lymphatic system cancer	0.00697	0.00697	CcSEcCtD
Gentamicin—Extravasation—Mitoxantrone—lymphatic system cancer	0.00694	0.00694	CcSEcCtD
Gentamicin—Pulmonary fibrosis—Methotrexate—lymphatic system cancer	0.00686	0.00686	CcSEcCtD
Gentamicin—Hypocalcaemia—Mitoxantrone—lymphatic system cancer	0.00661	0.00661	CcSEcCtD
Gentamicin—Neuropathy peripheral—Teniposide—lymphatic system cancer	0.00635	0.00635	CcSEcCtD
Gentamicin—Stomatitis—Teniposide—lymphatic system cancer	0.00631	0.00631	CcSEcCtD
Gentamicin—Phlebitis—Bleomycin—lymphatic system cancer	0.00628	0.00628	CcSEcCtD
Gentamicin—Vertigo—Mechlorethamine—lymphatic system cancer	0.00617	0.00617	CcSEcCtD
Gentamicin—Leukopenia—Mechlorethamine—lymphatic system cancer	0.00614	0.00614	CcSEcCtD
Gentamicin—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.0056	0.0056	CcSEcCtD
Gentamicin—Neuropathy peripheral—Fludarabine—lymphatic system cancer	0.00558	0.00558	CcSEcCtD
Gentamicin—Stomatitis—Fludarabine—lymphatic system cancer	0.00555	0.00555	CcSEcCtD
Gentamicin—Phlebitis—Carmustine—lymphatic system cancer	0.00549	0.00549	CcSEcCtD
Gentamicin—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.00548	0.00548	CcSEcCtD
Gentamicin—Alopecia—Teniposide—lymphatic system cancer	0.00514	0.00514	CcSEcCtD
Gentamicin—Phlebitis—Mitoxantrone—lymphatic system cancer	0.0051	0.0051	CcSEcCtD
Gentamicin—Hypoaesthesia—Fludarabine—lymphatic system cancer	0.00508	0.00508	CcSEcCtD
Gentamicin—Deafness—Vincristine—lymphatic system cancer	0.00504	0.00504	CcSEcCtD
Gentamicin—Visual impairment—Fludarabine—lymphatic system cancer	0.00492	0.00492	CcSEcCtD
Gentamicin—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00487	0.00487	CcSEcCtD
Gentamicin—Encephalopathy—Methotrexate—lymphatic system cancer	0.0047	0.0047	CcSEcCtD
Gentamicin—Anaemia—Teniposide—lymphatic system cancer	0.00468	0.00468	CcSEcCtD
Gentamicin—Anaphylactoid reaction—Mitoxantrone—lymphatic system cancer	0.00454	0.00454	CcSEcCtD
Gentamicin—Leukopenia—Teniposide—lymphatic system cancer	0.00453	0.00453	CcSEcCtD
Gentamicin—Alopecia—Fludarabine—lymphatic system cancer	0.00451	0.00451	CcSEcCtD
Gentamicin—Hypertension—Teniposide—lymphatic system cancer	0.00437	0.00437	CcSEcCtD
Gentamicin—Hypokalaemia—Carmustine—lymphatic system cancer	0.0043	0.0043	CcSEcCtD
Gentamicin—Weight decreased—Bleomycin—lymphatic system cancer	0.00423	0.00423	CcSEcCtD
Gentamicin—Muscular weakness—Carmustine—lymphatic system cancer	0.00417	0.00417	CcSEcCtD
Gentamicin—Confusional state—Teniposide—lymphatic system cancer	0.00416	0.00416	CcSEcCtD
Gentamicin—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00413	0.00413	CcSEcCtD
Gentamicin—Anaemia—Fludarabine—lymphatic system cancer	0.00411	0.00411	CcSEcCtD
Gentamicin—Stomatitis—Bleomycin—lymphatic system cancer	0.00407	0.00407	CcSEcCtD
Gentamicin—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00404	0.00404	CcSEcCtD
Gentamicin—Hypokalaemia—Mitoxantrone—lymphatic system cancer	0.004	0.004	CcSEcCtD
Gentamicin—Leukopenia—Fludarabine—lymphatic system cancer	0.00398	0.00398	CcSEcCtD
Gentamicin—Muscular weakness—Vincristine—lymphatic system cancer	0.00398	0.00398	CcSEcCtD
Gentamicin—Pruritus—Mechlorethamine—lymphatic system cancer	0.00396	0.00396	CcSEcCtD
Gentamicin—Hypotension—Teniposide—lymphatic system cancer	0.00386	0.00386	CcSEcCtD
Gentamicin—Convulsion—Fludarabine—lymphatic system cancer	0.00385	0.00385	CcSEcCtD
Gentamicin—Arthralgia—Fludarabine—lymphatic system cancer	0.00379	0.00379	CcSEcCtD
Gentamicin—Hypoaesthesia—Bleomycin—lymphatic system cancer	0.00373	0.00373	CcSEcCtD
Gentamicin—Confusional state—Fludarabine—lymphatic system cancer	0.00366	0.00366	CcSEcCtD
Gentamicin—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00363	0.00363	CcSEcCtD
Gentamicin—Decreased appetite—Teniposide—lymphatic system cancer	0.00359	0.00359	CcSEcCtD
Gentamicin—Neuropathy peripheral—Carmustine—lymphatic system cancer	0.00357	0.00357	CcSEcCtD
Gentamicin—Vomiting—Mechlorethamine—lymphatic system cancer	0.00356	0.00356	CcSEcCtD
Gentamicin—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00355	0.00355	CcSEcCtD
Gentamicin—Stomatitis—Carmustine—lymphatic system cancer	0.00355	0.00355	CcSEcCtD
Gentamicin—Rash—Mechlorethamine—lymphatic system cancer	0.00353	0.00353	CcSEcCtD
Gentamicin—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00353	0.00353	CcSEcCtD
Gentamicin—Weight decreased—Vincristine—lymphatic system cancer	0.00353	0.00353	CcSEcCtD
Gentamicin—Extravasation—Methotrexate—lymphatic system cancer	0.00346	0.00346	CcSEcCtD
Gentamicin—Weight decreased—Mitoxantrone—lymphatic system cancer	0.00344	0.00344	CcSEcCtD
Gentamicin—Neuropathy peripheral—Vincristine—lymphatic system cancer	0.00341	0.00341	CcSEcCtD
Gentamicin—Feeling abnormal—Teniposide—lymphatic system cancer	0.0034	0.0034	CcSEcCtD
Gentamicin—Stomatitis—Vincristine—lymphatic system cancer	0.00339	0.00339	CcSEcCtD
Gentamicin—Nausea—Mechlorethamine—lymphatic system cancer	0.00333	0.00333	CcSEcCtD
Gentamicin—Alopecia—Bleomycin—lymphatic system cancer	0.00331	0.00331	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00331	0.00331	CcSEcCtD
Gentamicin—Stomatitis—Mitoxantrone—lymphatic system cancer	0.0033	0.0033	CcSEcCtD
Gentamicin—Urticaria—Teniposide—lymphatic system cancer	0.00328	0.00328	CcSEcCtD
Gentamicin—Oliguria—Methotrexate—lymphatic system cancer	0.00327	0.00327	CcSEcCtD
Gentamicin—Body temperature increased—Teniposide—lymphatic system cancer	0.00326	0.00326	CcSEcCtD
Gentamicin—Erythema—Bleomycin—lymphatic system cancer	0.00326	0.00326	CcSEcCtD
Gentamicin—Paraesthesia—Fludarabine—lymphatic system cancer	0.00326	0.00326	CcSEcCtD
Gentamicin—Hallucination—Carmustine—lymphatic system cancer	0.00325	0.00325	CcSEcCtD
Gentamicin—Hypoaesthesia—Carmustine—lymphatic system cancer	0.00325	0.00325	CcSEcCtD
Gentamicin—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00316	0.00316	CcSEcCtD
Gentamicin—Decreased appetite—Fludarabine—lymphatic system cancer	0.00316	0.00316	CcSEcCtD
Gentamicin—Visual impairment—Carmustine—lymphatic system cancer	0.00315	0.00315	CcSEcCtD
Gentamicin—Hallucination—Vincristine—lymphatic system cancer	0.00311	0.00311	CcSEcCtD
Gentamicin—Hypoaesthesia—Vincristine—lymphatic system cancer	0.00311	0.00311	CcSEcCtD
Gentamicin—Hypersensitivity—Teniposide—lymphatic system cancer	0.00304	0.00304	CcSEcCtD
Gentamicin—Anaemia—Bleomycin—lymphatic system cancer	0.00301	0.00301	CcSEcCtD
Gentamicin—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00299	0.00299	CcSEcCtD
Gentamicin—Pruritus—Teniposide—lymphatic system cancer	0.00292	0.00292	CcSEcCtD
Gentamicin—Leukopenia—Bleomycin—lymphatic system cancer	0.00292	0.00292	CcSEcCtD
Gentamicin—Alopecia—Carmustine—lymphatic system cancer	0.00289	0.00289	CcSEcCtD
Gentamicin—Body temperature increased—Fludarabine—lymphatic system cancer	0.00287	0.00287	CcSEcCtD
Gentamicin—Erythema—Carmustine—lymphatic system cancer	0.00285	0.00285	CcSEcCtD
Gentamicin—Alopecia—Vincristine—lymphatic system cancer	0.00276	0.00276	CcSEcCtD
Gentamicin—Alopecia—Mitoxantrone—lymphatic system cancer	0.00269	0.00269	CcSEcCtD
Gentamicin—Confusional state—Bleomycin—lymphatic system cancer	0.00268	0.00268	CcSEcCtD
Gentamicin—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00267	0.00267	CcSEcCtD
Gentamicin—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00266	0.00266	CcSEcCtD
Gentamicin—Erythema—Mitoxantrone—lymphatic system cancer	0.00265	0.00265	CcSEcCtD
Gentamicin—Anaemia—Carmustine—lymphatic system cancer	0.00263	0.00263	CcSEcCtD
Gentamicin—Vomiting—Teniposide—lymphatic system cancer	0.00263	0.00263	CcSEcCtD
Gentamicin—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00261	0.00261	CcSEcCtD
Gentamicin—Rash—Teniposide—lymphatic system cancer	0.0026	0.0026	CcSEcCtD
Gentamicin—Dermatitis—Teniposide—lymphatic system cancer	0.0026	0.0026	CcSEcCtD
Gentamicin—Headache—Teniposide—lymphatic system cancer	0.00259	0.00259	CcSEcCtD
Gentamicin—Pruritus—Fludarabine—lymphatic system cancer	0.00257	0.00257	CcSEcCtD
Gentamicin—Leukopenia—Carmustine—lymphatic system cancer	0.00255	0.00255	CcSEcCtD
Gentamicin—Anaemia—Vincristine—lymphatic system cancer	0.00251	0.00251	CcSEcCtD
Gentamicin—Hypotension—Bleomycin—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Gentamicin—Convulsion—Carmustine—lymphatic system cancer	0.00247	0.00247	CcSEcCtD
Gentamicin—Hypertension—Carmustine—lymphatic system cancer	0.00246	0.00246	CcSEcCtD
Gentamicin—Nausea—Teniposide—lymphatic system cancer	0.00245	0.00245	CcSEcCtD
Gentamicin—Anaemia—Mitoxantrone—lymphatic system cancer	0.00245	0.00245	CcSEcCtD
Gentamicin—Vertigo—Vincristine—lymphatic system cancer	0.00244	0.00244	CcSEcCtD
Gentamicin—Leukopenia—Vincristine—lymphatic system cancer	0.00243	0.00243	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00242	0.00242	CcSEcCtD
Gentamicin—Paraesthesia—Bleomycin—lymphatic system cancer	0.00239	0.00239	CcSEcCtD
Gentamicin—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00237	0.00237	CcSEcCtD
Gentamicin—Convulsion—Vincristine—lymphatic system cancer	0.00235	0.00235	CcSEcCtD
Gentamicin—Hypertension—Vincristine—lymphatic system cancer	0.00235	0.00235	CcSEcCtD
Gentamicin—Confusional state—Carmustine—lymphatic system cancer	0.00234	0.00234	CcSEcCtD
Gentamicin—Decreased appetite—Bleomycin—lymphatic system cancer	0.00231	0.00231	CcSEcCtD
Gentamicin—Visual disturbance—Methotrexate—lymphatic system cancer	0.00231	0.00231	CcSEcCtD
Gentamicin—Vomiting—Fludarabine—lymphatic system cancer	0.00231	0.00231	CcSEcCtD
Gentamicin—Convulsion—Mitoxantrone—lymphatic system cancer	0.00229	0.00229	CcSEcCtD
Gentamicin—Rash—Fludarabine—lymphatic system cancer	0.00229	0.00229	CcSEcCtD
Gentamicin—Dermatitis—Fludarabine—lymphatic system cancer	0.00229	0.00229	CcSEcCtD
Gentamicin—Hypertension—Mitoxantrone—lymphatic system cancer	0.00228	0.00228	CcSEcCtD
Gentamicin—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00227	0.00227	CcSEcCtD
Gentamicin—Headache—Fludarabine—lymphatic system cancer	0.00227	0.00227	CcSEcCtD
Gentamicin—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.00226	0.00226	CcSEcCtD
Gentamicin—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00225	0.00225	CcSEcCtD
Gentamicin—Lethargy—Methotrexate—lymphatic system cancer	0.00223	0.00223	CcSEcCtD
Gentamicin—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00222	0.00222	CcSEcCtD
Gentamicin—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00219	0.00219	CcSEcCtD
Gentamicin—Confusional state—Mitoxantrone—lymphatic system cancer	0.00218	0.00218	CcSEcCtD
Gentamicin—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00217	0.00217	CcSEcCtD
Gentamicin—Hypotension—Carmustine—lymphatic system cancer	0.00217	0.00217	CcSEcCtD
Gentamicin—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00216	0.00216	CcSEcCtD
Gentamicin—Nausea—Fludarabine—lymphatic system cancer	0.00216	0.00216	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00212	0.00212	CcSEcCtD
Gentamicin—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00211	0.00211	CcSEcCtD
Gentamicin—Urticaria—Bleomycin—lymphatic system cancer	0.00211	0.00211	CcSEcCtD
Gentamicin—Body temperature increased—Bleomycin—lymphatic system cancer	0.0021	0.0021	CcSEcCtD
Gentamicin—Paraesthesia—Carmustine—lymphatic system cancer	0.00209	0.00209	CcSEcCtD
Gentamicin—Hypotension—Vincristine—lymphatic system cancer	0.00207	0.00207	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00202	0.00202	CcSEcCtD
Gentamicin—Decreased appetite—Carmustine—lymphatic system cancer	0.00202	0.00202	CcSEcCtD
Gentamicin—Hypotension—Mitoxantrone—lymphatic system cancer	0.00202	0.00202	CcSEcCtD
Gentamicin—Paraesthesia—Vincristine—lymphatic system cancer	0.00199	0.00199	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00197	0.00197	CcSEcCtD
Gentamicin—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00196	0.00196	CcSEcCtD
Gentamicin—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Gentamicin—Decreased appetite—Vincristine—lymphatic system cancer	0.00193	0.00193	CcSEcCtD
Gentamicin—Feeling abnormal—Carmustine—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Gentamicin—Pruritus—Bleomycin—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Gentamicin—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Gentamicin—Eosinophilia—Methotrexate—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Gentamicin—Body temperature increased—Carmustine—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Gentamicin—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Gentamicin—Body temperature increased—Vincristine—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Gentamicin—Urticaria—Mitoxantrone—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Gentamicin—Hypersensitivity—Carmustine—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Gentamicin—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Gentamicin—Vomiting—Bleomycin—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Gentamicin—Rash—Bleomycin—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Gentamicin—Dermatitis—Bleomycin—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Gentamicin—Stomatitis—Methotrexate—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Gentamicin—Hypersensitivity—Vincristine—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Gentamicin—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Gentamicin—Nausea—Bleomycin—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Gentamicin—Agranulocytosis—Methotrexate—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Gentamicin—Dizziness—Carmustine—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Gentamicin—Vomiting—Carmustine—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Gentamicin—Dizziness—Vincristine—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Gentamicin—Rash—Carmustine—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Gentamicin—Dermatitis—Carmustine—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Gentamicin—Visual impairment—Methotrexate—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Gentamicin—Headache—Carmustine—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Gentamicin—Tinnitus—Methotrexate—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Gentamicin—Vomiting—Vincristine—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Gentamicin—Rash—Vincristine—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Gentamicin—Dermatitis—Vincristine—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Gentamicin—Headache—Vincristine—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Gentamicin—Nausea—Carmustine—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Gentamicin—Vomiting—Mitoxantrone—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Gentamicin—Rash—Mitoxantrone—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Gentamicin—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Gentamicin—Headache—Mitoxantrone—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Gentamicin—Alopecia—Methotrexate—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Gentamicin—Erythema—Methotrexate—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Gentamicin—Nausea—Vincristine—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Gentamicin—Nausea—Mitoxantrone—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Gentamicin—Anaemia—Methotrexate—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Gentamicin—Vertigo—Methotrexate—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Gentamicin—Leukopenia—Methotrexate—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Gentamicin—Convulsion—Methotrexate—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Gentamicin—Arthralgia—Methotrexate—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Gentamicin—Confusional state—Methotrexate—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Gentamicin—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Gentamicin—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Gentamicin—Hypotension—Methotrexate—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.00098	0.00098	CcSEcCtD
Gentamicin—Paraesthesia—Methotrexate—lymphatic system cancer	0.000966	0.000966	CcSEcCtD
Gentamicin—Decreased appetite—Methotrexate—lymphatic system cancer	0.000935	0.000935	CcSEcCtD
Gentamicin—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000887	0.000887	CcSEcCtD
Gentamicin—Urticaria—Methotrexate—lymphatic system cancer	0.000855	0.000855	CcSEcCtD
Gentamicin—Body temperature increased—Methotrexate—lymphatic system cancer	0.000851	0.000851	CcSEcCtD
Gentamicin—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000793	0.000793	CcSEcCtD
Gentamicin—Pruritus—Methotrexate—lymphatic system cancer	0.000761	0.000761	CcSEcCtD
Gentamicin—Dizziness—Methotrexate—lymphatic system cancer	0.000711	0.000711	CcSEcCtD
Gentamicin—Vomiting—Methotrexate—lymphatic system cancer	0.000684	0.000684	CcSEcCtD
Gentamicin—Rash—Methotrexate—lymphatic system cancer	0.000678	0.000678	CcSEcCtD
Gentamicin—Dermatitis—Methotrexate—lymphatic system cancer	0.000678	0.000678	CcSEcCtD
Gentamicin—Headache—Methotrexate—lymphatic system cancer	0.000674	0.000674	CcSEcCtD
Gentamicin—Nausea—Methotrexate—lymphatic system cancer	0.000639	0.000639	CcSEcCtD
